current
frequenc
canin
parvoviru
variant
argentin
dog
popul
investig
pcr
amplif
bp
fragment
gene
total
rectal
swab
sampl
submit
laboratori
sinc
result
posit
analyz
direct
dna
sequenc
fifti
posit
sampl
character
variant
appear
argentina
year
preval
type
sinc
wherea
still
found
argentin
dog
repres
popul
respect
consid
spread
worldwid
variant
also
affect
vaccin
dog
effort
made
toward
develop
new
match
cpv
vaccin
four
differ
famili
anim
virus
identifi
etiolog
agent
sever
enter
dog
canin
parvoviru
cpv
canin
coronaviru
canin
rotaviru
canin
distemp
viru
mochizuki
et
al
pollock
carmichael
decaro
et
al
sever
diseas
rapid
spread
throughout
canin
popul
cpv
arisen
great
deal
public
interest
cpv
nonenvelop
viru
singlestrand
dna
genom
approxim
base
encod
two
structur
two
nonstructur
protein
cotmor
tattersal
cpv
first
identifi
may
new
viru
infect
dog
parrish
kawaoka
kapil
et
al
late
earli
live
inactiv
felin
panleukopenia
fpl
vaccin
use
protect
dog
cpv
diseas
howev
level
protect
afford
poor
durat
immun
short
vaccin
replac
live
attenu
cpv
vaccin
provid
good
protect
longer
last
immun
spibey
et
al
biolog
properti
viru
particularli
rate
nucleotid
substitut
closer
rna
virus
correspond
author
tel
fax
email
address
jlatorrecevan
centromilsteinorgar
j
la
torr
aprox
doublestrand
dna
virus
shackelton
et
al
determin
continu
appear
new
variant
high
sanitari
impact
vaccin
unvaccin
dog
popul
two
antigen
variant
name
appear
year
discoveri
first
character
current
origin
strain
circul
dog
popul
although
still
present
vaccin
formul
wherea
variant
distribut
worldwid
parrish
et
al
martella
et
al
decaro
et
al
mochizuki
et
al
buonavoglia
et
al
de
ybanez
et
al
greenwood
et
al
sagazio
et
al
steinel
et
al
truyen
et
al
pereira
et
al
caval
et
al
buonavoglia
et
al
martella
et
al
martella
et
al
truyen
et
al
martella
et
al
differ
origin
type
strain
presenc
five
amino
acid
aa
chang
coat
protein
antigen
differ
observ
consequ
one
aa
substitut
locat
major
antigen
site
capsid
epitop
parrish
et
al
new
antigen
variant
carri
aa
substitut
major
antigen
site
viral
capsid
protein
report
itali
year
buonavoglia
et
al
desario
et
al
newest
variant
design
alreadi
detect
european
countri
well
asia
africa
america
decaro
et
al
b
nakamura
et
al
kapil
et
al
martella
et
al
decaro
et
al
hong
et
al
perez
et
al
joao
vieira
et
al
calderon
et
al
nandi
et
al
import
emphas
updat
methodolog
incorpor
minor
groov
binder
probe
technolog
well
pcr
amplif
follow
sequenc
allow
precis
identif
emerg
cpv
variant
therefor
becom
import
tool
studi
cpv
epidemiolog
decaro
et
al
decaro
et
al
decaro
et
al
present
studi
report
updat
identif
character
differ
cpv
variant
argentina
total
rectal
swab
sampl
obtain
domest
dog
argentin
citi
bueno
air
n
dolor
n
tandil
n
n
mar
del
plata
n
blanca
n
n
mision
n
negro
n
locat
km
bueno
air
respect
sampl
paraguay
also
analyz
origin
two
sampl
unknown
clinic
specimen
submit
laboratori
diagnost
purpos
year
inform
anim
whose
sampl
test
posit
cpv
clinic
symptom
age
gender
breed
vaccin
statu
provid
tabl
cpv
genom
dna
extract
directli
rectal
swab
commerci
vaccin
vanguard
plu
cpv
pfizer
lysi
buffer
contain
mm
trishcl
ph
mm
nacl
mm
sucros
mm
edta
sd
lysi
extract
digest
proteinas
k
invitrogen
usa
c
min
dna
extract
phenolchloroform
amplif
larg
fragment
capsid
proteinencod
gene
cpv
primer
set
use
result
product
bp
compris
least
six
seven
inform
aa
respons
import
biolog
properti
viru
buonavoglia
et
al
pcr
amplif
perform
use
taq
recombin
polymeras
invitrogen
usa
mj
research
cycler
sierra
point
ca
initi
denatur
step
c
min
follow
cycl
pcr
c
c
c
final
concentr
mgcl
mm
dna
fragment
amplifi
clinic
sampl
directli
sequenc
dideoxymedi
chaintermin
method
macrogen
inc
korea
multipl
sequenc
align
analysi
perform
use
clustalw
genbank
access
number
aa
nucleotid
sequenc
refer
cpv
strain
cpvb
strain
strain
strain
genbank
access
number
nucleotid
sequenc
dna
fragment
amplifi
local
variant
sampl
paraguay
practic
purpos
ident
sequenc
group
one
regist
databas
studi
rectal
swab
sampl
anim
suspect
cpv
infect
test
cpv
specif
dna
detect
pcr
amplif
bp
fragment
analyz
rectal
swab
dna
extract
commerci
vaccin
use
posit
control
case
obtain
pcr
product
analyz
electrophoret
differ
found
size
amplicon
data
shown
neg
sampl
assay
twice
confirm
result
fortynin
posit
anim
show
clinic
symptom
compat
cpv
record
avail
six
dog
interestingli
posit
sampl
recov
month
old
puppi
tabl
fortythre
obtain
puppi
vaccin
cpv
least
wherea
eleven
obtain
unvaccin
dog
vaccin
statu
remain
dog
unknown
relationship
could
establish
regard
sex
breed
tabl
order
identifi
differenti
cpv
variant
local
clinic
sampl
pcr
product
posit
sampl
sequenc
deduc
aa
sequenc
align
fig
show
result
sequenc
align
posit
deriv
seven
repres
local
field
sampl
identifi
along
sequenc
vaccin
strain
three
intern
refer
strain
posit
variant
show
asn
n
asp
wherea
variant
show
glu
e
residu
similar
analysi
perform
cpv
posit
sampl
reveal
carri
mutat
characterist
variant
wherea
two
sampl
character
remain
three
defin
data
shown
addit
aa
align
perform
complet
bp
amplif
product
show
low
degre
variat
among
argentin
variant
observ
accord
previou
report
author
decaro
et
al
kapil
et
al
pereira
et
al
result
shown
fig
besid
aa
substitut
posit
analysi
sequenc
argentin
cpv
variant
show
appear
new
mutat
restrict
local
variant
whose
worldwid
presenc
recent
report
decaro
et
al
kapil
et
al
hong
et
al
chinchkar
et
al
kang
et
al
analysi
perform
clearli
demonstr
sampl
character
obtain
present
typic
aa
posit
wherea
seen
fig
distribut
variant
accord
age
clearli
show
major
puppi
affect
variant
sampl
belong
monthold
puppi
present
work
repres
updat
incid
differ
cpv
variant
argentina
includ
case
character
previou
report
calderon
et
al
although
first
detect
result
present
herein
clearli
show
becom
predomin
variant
sinc
year
sampl
analyz
found
carri
typic
aa
substitut
tabl
fig
addit
mutat
locat
expos
domain
capsid
protein
also
found
sampl
fig
agreement
previou
report
decaro
et
al
kapil
et
al
hong
et
al
chinchkar
et
al
kang
et
al
interest
point
mutat
found
exclus
sampl
collect
year
indic
recent
appear
argentin
dog
popul
correl
substitut
biolog
properti
viru
still
unknown
sinc
locat
import
domain
expos
select
pressur
vaccin
colostr
antibodi
epidemiolog
surveil
requir
investig
evolut
behavior
eventu
sanitari
impact
virus
carri
mutat
hoelzer
parrish
hoskin
except
two
relev
aa
substitut
mention
low
degre
variabl
found
sequenc
argentin
field
variant
observ
agreement
previou
report
region
world
decaro
et
al
report
dog
infect
newest
variant
show
frequent
atyp
clinic
symptom
thu
make
diagnosi
cpv
diseas
difficult
addit
classic
diagnost
procedur
suitabl
precis
cpv
strain
identif
tradit
pcr
amplif
bp
fragment
show
effect
detect
cpv
dna
size
pcr
product
deriv
indistinguish
sequenc
mandatori
allow
precis
identif
variant
clinic
sampl
analyz
work
obtain
popul
compos
predominantli
young
puppi
submit
laboratori
associ
dog
breeder
veterinarian
result
clearli
show
higher
incid
puppi
peak
anim
fig
vaccin
statu
particular
popul
variabl
anim
receiv
one
three
dose
vaccin
although
find
need
confirm
analyz
larger
number
anim
may
specul
earli
age
weak
even
gap
protect
statu
puppi
probabl
due
low
level
matern
antibodi
presenc
immatur
immun
system
unabl
respond
properli
vaccin
similar
result
report
laboratori
case
calf
neonat
diarrhea
caus
rotaviru
bellinzoni
et
al
strong
increas
level
colostr
antibodi
demonstr
case
immun
pregnant
dam
day
prior
deliveri
feed
expos
calv
hyperimmun
colostrum
therefor
vaccin
pregnant
bitch
might
also
increas
specif
colostr
milk
antibodi
level
dog
help
deal
infect
young
puppi
anoth
possibl
might
develop
improv
vaccin
updat
vaccin
schedul
order
induc
effect
earli
protect
respons
canin
parvoviru
evolut
rapid
spread
dog
popul
rais
concern
among
breeder
owner
veterinari
practition
need
updat
current
cpv
vaccin
truyen
addit
complementari
sanitari
measur
increas
biosecur
level
breed
premis
implement
stronger
sanitari
regul
trade
exhibit
live
dog
could
also
relev
